FY2024 EPS Estimates for Addus HomeCare Lifted by Analyst

Addus HomeCare Co. (NASDAQ:ADUS) – KeyCorp boosted their FY2024 earnings estimates for shares of Addus HomeCare in a research note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor now forecasts that the company will post earnings of $4.52 per share for the year, up from their prior forecast of $4.50. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Addus HomeCare’s current full-year earnings is $4.59 per share. KeyCorp also issued estimates for Addus HomeCare’s Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.31 EPS, Q3 2025 earnings at $1.34 EPS, Q4 2025 earnings at $1.47 EPS and FY2025 earnings at $5.26 EPS.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.03 EPS.

Several other brokerages also recently weighed in on ADUS. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities began coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Finally, Macquarie reiterated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $133.67.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $126.42 on Thursday. The firm has a market capitalization of $2.29 billion, a P/E ratio of 28.93, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.12. The company’s 50-day moving average is $125.04 and its 200 day moving average is $125.95.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ADUS. Texas Permanent School Fund Corp increased its holdings in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after acquiring an additional 82 shares in the last quarter. Arizona State Retirement System increased its stake in Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after purchasing an additional 87 shares in the last quarter. Inspire Investing LLC lifted its stake in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares during the period. New York State Teachers Retirement System lifted its stake in shares of Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after buying an additional 100 shares during the period. Finally, Equitable Trust Co. grew its holdings in shares of Addus HomeCare by 2.2% during the third quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after buying an additional 106 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.